SeraCare Life Sciences to Present at Thomas Weisel Partners Healthcare Conference

* Reuters is not responsible for the content in this press release.

Wed Aug 27, 2008 10:02am EDT 

MILFORD, Mass.--(Business Wire)--
SeraCare Life Sciences, Inc. (NASDAQ: SRLS) today announced that
the Company will present at the Thomas Weisel Partners Healthcare
Conference on Thursday, September 4, 2008 at 3:15 PM Eastern Time at
the Four Seasons Hotel in Boston. Susan Vogt, President and CEO of
SeraCare, will present an overview of the Company's business strategy,
including core products and services and key initiatives that directly
support SeraCare's global growth strategy. SeraCare serves the global
life sciences industry by providing vital products and services to
facilitate the discovery, validation and production of human
diagnostics and therapeutics.

   A live audio webcast and replay of the presentation will be
available in the "Investor Relations" section of the Company's
website, www.seracare.com.

   About SeraCare Life Sciences:

   SeraCare serves the global life sciences industry by providing
vital products and services to facilitate the discovery, validation
and production of human diagnostics and therapeutics. SeraCare's
innovative portfolio includes diagnostic controls, plasma-derived
reagents and molecular biomarkers, biobanking and contract research
services. SeraCare's quality systems, scientific expertise and
state-of-the-art facilities support its customers in meeting the
stringent requirements of the highly regulated life sciences industry.

SeraCare Life Sciences, Inc.
Chief Financial Officer
Gregory A. Gould, 508-244-6400
or
Investor Relations
MacDougall Biomedical Communications
Sarah Cavanaugh, 781-235-3060

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.